Par Drugs IPO vs Suich Industries IPO

Comparison between Par Drugs IPO and Suich Industries IPO.

IPO Details

Par Drugs IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Suich Industries IPO is a SME Bookbuilding proposed to list at BSE SME.

Issue Size and Price

The total issue size of Par Drugs IPO is up to ₹8.10 Cr whereas the issue size of the Suich Industries IPO is up to ₹29.30 Cr. The final issue price of Par Drugs IPO is ₹51.00 per share and of Suich Industries IPO is ₹75.00 per share.

 Par Drugs IPOSuich Industries IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)₹73.00 per share
Issue Price (Upper)₹75.00 per share
Issue Price (Final)₹51.00 per share₹75.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Discount (Employee)₹0.00 per share
Market Lot Size2000 shares1600 shares
Fresh Issue Size15,88,000 shares39,07,200 shares
Fresh Issue Size (Amount)up to ₹8.10 Crup to ₹29.30 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total15,88,000 shares39,07,200 shares
Issue Size Total (Amount)up to ₹8.10 Crup to ₹29.30 Cr

IPO Timetable

Par Drugs IPO opens on May 03, 2019, while Suich Industries IPO opens on May 30, 2019. The closing date of Par Drugs IPO and Suich Industries IPO is May 08, 2019, and Jun 04, 2019, respectively.

 Par Drugs IPOSuich Industries IPO
Issue OpenMay 03, 2019May 30, 2019
Issue CloseMay 08, 2019Jun 04, 2019
Basis Of Allotment (Tentative)May 13, 2019Jun 10, 2019
Initiation of Refunds (Tentative)May 14, 2019Jun 11, 2019
Credit of Share (Tentative)May 15, 2019Jun 12, 2019
Listing date (Tentative)May 16, 2019Jun 13, 2019

Financials & KPIs

Par Drugs IPO P/E ratio is , as compared to Suich Industries IPO P/E ratio of .

 Par Drugs IPOSuich Industries IPO
Financials

Company Financials (Restated Standalone)

Period Ended31 Mar 201931 Mar 201831 Mar 2017
Assets51.3653.9456.04
Total Income46.4142.4248.81
Profit After Tax2.421.501.85
EBITDA5.288.028.50
NET Worth29.1220.7019.20
Reserves and Surplus24.6412.2510.75
Total Borrowing11.5823.1324.81
Amount in ₹ Crore

Company Financials (Restated Consolidated)

Period Ended31 Dec 201831 Mar 201831 Mar 201731 Mar 2016
Assets114.18140.4272.7178.96
Total Income140.16202.79144.37106.58
Profit After Tax11.487.435.333.01
EBITDA19.3216.1513.189.96
NET Worth51.7340.2732.8527.52
Reserves and Surplus40.6029.1421.7216.39
Total Borrowing34.4438.4428.2227.31
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)99.55%95.5%
Promoter Shareholding (Post-Issue)72.5%69.72%
Market Cap₹31.38 Cr.₹114.33 Cr.

Shares Offered

In the Par Drugs IPO Retail Individual Investors (RII) are offered 7,80,000 shares while in Suich Industries IPO retail investors are offered 7,80,000 shares. Qualified Institutional Buyers (QIB) are offered in Par Drugs IPO and in Suich Industries IPO.

 Par Drugs IPOSuich Industries IPO
Market Maker Reservation84,000 shares2,08,000 shares
NII7,78,000 shares19,52,000 shares
RII7,80,000 shares19,55,200 shares
Employee30,000 shares
Total15,88,000 shares39,07,200 shares

Bids Received (Subscription)

Par Drugs IPO subscribed 5.64x in total, whereas Suich Industries IPO subscribed 1.39x.

 Par Drugs IPOSuich Industries IPO
NII (times)3.48x1.32x
RII (times)7.97x1.47x
Employee (times)1.00x
Total (times)5.64x1.39x

Compare with others

Compare:

Par Drugs IPO Vs Suich Industries IPO